We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alaunos Therapeutics Inc | NASDAQ:TCRT | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -1.52% | 1.30 | 1.00 | 1.24 | 1.381 | 1.25 | 1.32 | 44,105 | 01:00:00 |
From May 2022 to May 2024
2022 Wells Fargo Healthcare Conference Date: Thursday, September 8, 2022 Format: 1x1 Meetings onlyLocation: Boston, MA
Morgan Stanley 20th Annual Global Healthcare Conference Date: Monday, September 12, 2022 Format: 1x1 Meetings onlyLocation: New York, NY
Cantor Oncology, Hematology & HemeOnc ConferenceDate: Wednesday, September 28, 2022 Format: Panel Presentation and 1x1 MeetingsPanel: Cell Therapy in Solid TumorsLocation: New York, NY
About Alaunos TherapeuticsAlaunos is a clinical-stage oncology-focused cell therapy company, focused on developing T-cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer technology and its TCR library targeting shared tumor-specific hotspot mutations in key oncogenic genes including KRAS, TP53 and EGFR. The Company has a clinical and strategic collaboration with the National Cancer Institute. For more information, please visit www.alaunos.com.
Investor Relations Contact:Alex LoboStern Investor Relationsalex.lobo@sternir.com
1 Year Alaunos Therapeutics Chart |
1 Month Alaunos Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
